Researchers have developed a novel vaccination approach using Quartet nanocages that display receptor-binding domains (RBDs) from different sarbecoviruses, showing enhanced immune responses and potential protection against diverse coronavirus strains including SARS-CoV-2 and its variants.
Latigo, a pain biotech years in the making, emerges with $135M on heels of Vertex PhIII success
On Valentine’s Day, a non-opioid drugmaker unveiled itself after nearly five years of courting drug candidates behind the scenes and working quietly “on the heels” of
February 15, 2024